About the Authors

Albert Liu, Darpun Sachdev, Susan Buchbinder
Bridge HIV, San Francisco Department of Public Health, San Francisco, California, United States of America

Albert Liu, Stephanie Cohen, Darpun Sachdev, Susan Buchbinder
Department of Medicine, University of California, San Francisco, San Francisco, California, United States of America

Stephanie Cohen
STD Prevention and Control, San Francisco Department of Public Health, San Francisco, California, United States of America

Stephen Follansbee
Kaiser Permanente Medical Center, San Francisco, California, United States of America

Deborah Cohan
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, San Francisco, California, United States of America

Shannon Weber
Department of Family and Community Medicine, University of California, San Francisco, San Francisco, California, United States of America

Susan Buchbinder
Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, United States of America

Corresponding Author

albert.liu@sfdph.org

Competing Interests

The only competing interest for Drs. Liu and Buchbinder is that they receive NIH grant funding for studies related to PrEP, including the demonstration project that is described in the paper. However, they receive no money from the pharmaceutical (Gilead) that makes PrEP, nor is NIH funding contingent upon receiving any specific results from that study.

Author Contributions

Conceived and designed the experiments: AL SC SF DC SW DS SB. Performed the experiments: AL SC SF DC SW SB. Analyzed the data: AL SC SF DC SW DS SB. Wrote the first draft of the manuscript: AL SC SF DC DS SB. Contributed to the writing of the manuscript: AL SC SF DC SW DS SB. ICMJE criteria for authorship read and met: AL SC SF DC SW DS SB. Agree with manuscript results and conclusions: AL SC SF DC SW DS SB. Enrolled patients: AL SC SF DC SB.